Assessing cognitive function in clinical
β
Jennifer H. Barnett; Trevor W. Robbins; Verity C. Leeson; Barbara J. Sahakian; E
π
Article
π
2010
π
Elsevier Science
π
English
β 435 KB
Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (